Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

Figure 2

Patient#1's lymphocytes in vitro proliferation in response to autologous tumor Ags presented by DCs. Pre and post vaccination Patient#1 PBMC were incubated either alone, with Apo-Nec#1 cells prepared from patient#1 tumor cells or with DC/Apo-Nec#1 cells; (H3) dThd incorporation was measured as described under Methods. Results represent mean ± SD cpm (counts per minute) of triplicates. Positive controls incubated with PHA incorporated more than 7 × 104 cpm (not shown).

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us